A Surface Plasmon Resonance Spectroscopy Method for Characterizing Small-Molecule Binding to Nerve Growth Factor.

Area of Science:

• Pharmacology
• Biochemistry
• Drug Discovery

Background:

• Small-molecule inhibitors are explored as therapeutics for chronic pain.
• Nerve growth factor (NGF) is a key target in pain management.
• Previous characterization of NGF inhibitors relied on indirect binding assays.

Purpose of the Study:

• To develop and validate a novel methodology for directly characterizing small-molecule nerve growth factor (NGF) inhibitors.
• To determine the binding affinity (KD) and saturation ability of known NGF inhibitors using surface plasmon resonance (SPR) spectroscopy.
• To identify NGF inhibitors with high binding affinity and saturation for further investigation as potential chronic pain therapeutics.

Main Methods:

• Utilized surface plasmon resonance (SPR) spectroscopy to evaluate binding kinetics.
• Immobilized nerve growth factor (NGF) on SPR sensor chips.
• Screened known NGF inhibitors, measuring binding affinity (KD) and percent saturation.

Main Results:

• A novel SPR-based methodology was successfully established for direct characterization of NGF inhibitors.
• Seventy-four percent of screened compounds exhibited a positive binding event with NGF.
• Thresholds of KD < 10 μM and percent saturation > 50% identified potent inhibitors.

Conclusions:

• The developed SPR methodology provides a direct and efficient means to characterize small-molecule NGF inhibitors.
• This approach facilitates the identification of promising drug candidates for chronic pain treatment.
• The study establishes a foundation for future drug discovery efforts targeting NGF.